Background The significance of lobular neoplasia (LN), lobular carcinoma in situ (LCIS) and
atypical lobular hyperplasia (ALH)) found at core needle biopsy (CNB) of the breast remains …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

BREAST CANCER RISK Page 1 EREA ET CANCER IN HICH-RIEK PATIENTE 1055–3207/93
3000 + 20 ATYPICAL DUCTAL AND LOBULAR HYPERPLASIA AND BREAST CANCER RISK …

OBJECTIVE. The aims of our study were to determine the frequency of malignancy after
surgical excision of biopsy-proven lobular carcinoma in situ (LCIS) or atypical lobular …

The appropriate follow-up and treatment for patients with a core biopsy diagnosis of lobular
neoplasia (atypical lobular hyperplasia or lobular carcinoma in situ) remains controversial …

▪ Abstract: LCIS was first described in 1941 as a distinct pathologic entity by Foote and
Stewart who called it a “rare form of mammary carcinoma.” It is thought to represent a …

PURPOSE: To review outcomes of lesions diagnosed at core-needle breast biopsy as
atypical lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS). MATERIALS AND …

RATIONALE AND OBJECTIVES: The purpose of this study was to review the imaging
findings associated with lobular carcinoma in situ (LCIS) of the breast with clinical and …

The current histological classification of in‐situ and invasive lobular carcinomas (ILCs)
includes different morphological variants, some of which have been recently described. In …

BACKGROUND. Atypical lobular hyperplasia (ALH) is associated with a 10% to 20% risk of
subsequent invasive carcinoma, primarily in the ipsilateral breast. Nottingham grading …